Home
Howard W. Robin, President & CEO: Nektar Therapeutics NKTR Sell · Filed 24/05/20
Trade details
- Type
- Insider sale
- Amount
- $29,137.5
- Shares · price
- 16,650 sh · $1.75 a share
- Held after
- 863,239 sh
- Trade date
- 24/05/17
- Filed
- 24/05/20
- Days to filing
- 3 days
Sold 1.9% of holdings
- Share of holding sold
- 1.9%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 24/04/17~24/06/16Howard W. Robin's recent trades
- Howard W. Robin
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$30.1K
418 sh
$30.1K
Filed 08/18
Traded 08/18
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$334.5K
5,500 sh
$334.5K
Filed 06/18
Traded 06/17
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$318K
5,303 sh
$318K
Filed 06/18
Traded 06/16
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$285.2K
4,697 sh
$285.2K
Filed 06/18
Traded 06/16
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$277.4K
4,500 sh
$277.4K
Filed 06/18
Traded 06/17